Author： Ballantyne Bryan
Publisher： Adis International
ISSN： 1176-2551
Source： Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews), Vol.23, Iss.2, 2004-01, pp. : 83-90
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Dexamethasone Ophthalmic - Oculex: Surodex
Drugs in R&D, Vol. 3, Iss. 3, 2002-01 ,pp. :
Access to resources
Recommend
Besifloxacin Ophthalmic Suspension 0.6%
By Carter Natalie J. Scott Lesley J.
Drugs, Vol. 70, Iss. 1, 2010-01 ,pp. :
Emerging drugs for ophthalmic diseases
Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. :
Hypersensitivity Reactions to Ophthalmic Products
Current Pharmaceutical Design, Vol. 12, Iss. 26, 2006-09 ,pp. :
Stability of Pilocarpine Ophthalmic Solutions
By Pilatti C. Torre M. Chiale C. Spinetto M.
Drug Development and Industrial Pharmacy, Vol. 25, Iss. 6, 1999-05 ,pp. :